Literature DB >> 7308718

Concentration and excretion of contrast agents during oral cholecystography as measured by computed tomography in dogs.

T B Hunter, G T Fon, R N Berk, M P Capp.   

Abstract

Nine healthy mongrel dogs were given 2 consecutive doses of 1 of 3 cholecystographic contrast agents (iopanoic acid, sodium ipodate, and sodium tyropanoate), followed by daily computed tomograms (CT) and abdominal radiographs in a randomized crossover study in order to determine: (a) the maximum time for excretion of the contrast material from the gallbladder, (b) the maximum time for elimination of contrast material from the blood, and (c) the correlation between the density of the gallbladder on CT and the actual concentration of iodine in the gallbladder bile. In all 9 animals gallbladder opacification disappeared on CT within 4 days after administration of the contrast material. Plain abdominal radiographs did not show gallbladder opacification after 2 1/2 days. Daily blood iodine measurements showed that all of the contrast material was cleared from the blood within 7 days after administration. In 7 dogs CT imaging of the gallbladder was followed by percutaneous aspiration of bile from the gallbladder using CT guidance. There was a direct linear correlation between the actual concentration of iodine in the bile and the density of the gallbladder on CT (r = 0.925). This suggests that CT measurements can be used to determine the concentration of contrast agents in the gallbladder during oral cholecystography.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308718     DOI: 10.1007/bf01890284

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN: 0364-2356


  10 in total

1.  Persistent gallbladder opacification after iopanoic acid cholecystography: diagnostic implications for acalculous cholecystitis.

Authors:  M P Banner; M H Bleshman; J M Speckman
Journal:  AJR Am J Roentgenol       Date:  1979-01       Impact factor: 3.959

2.  Observations on the metabolism of iodopanoic acid.

Authors:  E W McCHESNEY; J O HOPPE
Journal:  Arch Int Pharmacodyn Ther       Date:  1954-09-15

3.  Excretion of 3-(3-amino-2,4,6-triidophenyl)-2-ethyl-propanoic acid (Telepaque) by man.

Authors:  J S SCHRODER; D ROONEY
Journal:  Proc Soc Exp Biol Med       Date:  1953-07

4.  The effect of fasting on gallbladder opacification during oral cholecystography: a controlled study in normal volunteers.

Authors:  P M Loeb; R N Berk; J O Janes; L Perkin; J Moore
Journal:  Radiology       Date:  1978-02       Impact factor: 11.105

5.  Proceedings: Cholecystokinin cholecystography in acalculous gallbladder disease.

Authors:  P F Nora; W McCarthy; N Sanez
Journal:  Arch Surg       Date:  1974-04

6.  Urinary excretion of three oral cholecystographic agents in man.

Authors:  E W McChesney; W F Banks
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

7.  The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography.

Authors:  G T Fon; T B Hunter; R N Berk; M P Capp
Journal:  Radiology       Date:  1980-09       Impact factor: 11.105

8.  A diagnostic technique for acalculous cholecystitis.

Authors:  T W Adams; E G Foxley
Journal:  Surg Gynecol Obstet       Date:  1976-02

9.  Recirculation of iopanoic acid after conjugation in the liver.

Authors:  H I Goldberg; S K Lin; R Thoeni; A A Moss; A Brito
Journal:  Invest Radiol       Date:  1977 Nov-Dec       Impact factor: 6.016

10.  Prolonged gallbladder opacification after oral cholecystography.

Authors:  R E Koehler; R J Stanley; J DiCroce
Journal:  Radiology       Date:  1978-09       Impact factor: 11.105

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.